Table 1 Patient and treatment characteristics

Number of patients

66

Median age at diagnosis (range)

51.8 (23.3–90.1)

Histology

Squamous: 54 (82 %)

Adenocarcinoma: 7 (11 %)

Adenosquamous: 5 (8 %)

Grade (differentiation)

Well: 4 (6 %)

Moderate: 43 (65 %)

Poor: 19 (29 %)

FIGO Stage (2009)

IB1-2: 2 (3 %)

IIA1-IIB: 42 (64 %)

IIIA-B: 16 (24 %)

IVA-B: 6 (9 %)

Median External beam radiotherapy dose (range)

44.92 Gy (39.6–59.4)

Median HDR Brachytherapy dose (range)

27.05 Gy (21–28)

Median Total external beam and brachytherapy dose as an EQD2 (range)

82.2 Gy (74–83.9)

Concurrent chemotherapy

58 (88 %)